Back to Companies
GT Biopharma, Inc.
GTBPNasdaqCIK: 0000109657
Over the 6 most recent insider filings, GT Biopharma, Inc. (GTBP) has seen activity from 5 distinct insiders — no open-market buying or selling. Breen Michael Martin (CEO and Director, Director) is the most active by dollar volume, and the single largest transaction was $399.0K by Breen Michael Martin. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$698.3K
Purchases
$0
Sales
$0
Unique Insiders
5
Recent Insider Trades
6 loaded
| Sep 8 | GTBP GT Biopharma, Inc. | URBAN ALAN LOUIS | Chief Financial Officer | Award | $133.0K |
| Sep 8 | GTBP GT Biopharma, Inc. | Kramer Hilary | Director | Award | $41.6K |
| Sep 8 | GTBP GT Biopharma, Inc. | CASAMENTO CHARLES J | Director | Award | $83.1K |
| Sep 8 | GTBP GT Biopharma, Inc. | Breen Michael Martin | CEO and Director, Director | Award | $399.0K |
| Sep 8 | GTBP GT Biopharma, Inc. | Mun-Gavin David C. | Director | Award | $41.6K |
| Jul 30 | GTBP GT Biopharma, Inc. | Mun-Gavin David C. | Director | Other | $0 |
6 filings